- Home
- PBA vs WST Comparison
PBA vs WST Comparison
Compare PBA & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBA
- WST
- Stock Information
- Founded
- PBA 1997
- WST 1923
- Country
- PBA Canada
- WST United States
- Employees
- PBA N/A
- WST N/A
- Industry
- PBA Oil & Gas Production
- WST Medical/Dental Instruments
- Sector
- PBA Energy
- WST Health Care
- Exchange
- PBA Nasdaq
- WST Nasdaq
- Market Cap
- PBA 24.0B
- WST 23.2B
- IPO Year
- PBA N/A
- WST N/A
- Fundamental
- Price
- PBA $36.57
- WST $333.19
- Analyst Decision
- PBA Buy
- WST Strong Buy
- Analyst Count
- PBA 1
- WST 5
- Target Price
- PBA $57.00
- WST $437.75
- AVG Volume (30 Days)
- PBA 1.5M
- WST 482.3K
- Earning Date
- PBA 02-20-2025
- WST 02-13-2025
- Dividend Yield
- PBA 5.30%
- WST 0.25%
- EPS Growth
- PBA 51.43
- WST N/A
- EPS
- PBA 2.43
- WST 6.74
- Revenue
- PBA $7,305,229,650.00
- WST $2,876,400,000.00
- Revenue This Year
- PBA N/A
- WST N/A
- Revenue Next Year
- PBA $15.54
- WST $6.08
- P/E Ratio
- PBA $15.08
- WST $49.37
- Revenue Growth
- PBA 37.18
- WST N/A
- 52 Week Low
- PBA $32.81
- WST $265.00
- 52 Week High
- PBA $43.44
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- PBA 28.81
- WST 58.32
- Support Level
- PBA $38.75
- WST $325.33
- Resistance Level
- PBA $36.99
- WST $335.53
- Average True Range (ATR)
- PBA 0.65
- WST 7.63
- MACD
- PBA -0.13
- WST 0.36
- Stochastic Oscillator
- PBA 17.95
- WST 76.56
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.